# Emergent BioSolutions Inc. (EBS) — Gross Profit

## Annual Gross Profit (USD)

| Year | Gross Profit |
| --- | --- |
| 2025 | $417M |
| 2024 | $362M |
| 2023 | $318M |
| 2022 | $383M |
| 2021 | $891M |
| 2020 | $925M |
| 2019 | $673M |
| 2018 | $460M |
| 2017 | $373M |
| 2016 | $363M |
| 2015 | $415M |
| 2014 | $348M |
| 2013 | $251M |
| 2012 | $236M |
| 2011 | $231M |
| 2010 | $239M |
| 2009 | $189M |

## Quarterly Gross Profit (USD)

| Quarter | Gross Profit |
| --- | --- |
| 2026-03-31 | $84M |
| 2025-09-30 | $145M |
| 2025-06-30 | $74M |
| 2025-03-31 | $134M |
| 2024-09-30 | $161M |
| 2024-06-30 | -$48M |
| 2024-03-31 | $148M |
| 2023-09-30 | $87M |
| 2023-06-30 | $141M |
| 2023-03-31 | $5M |
| 2022-09-30 | $75M |
| 2022-06-30 | $66M |
| 2022-03-31 | $142M |
| 2021-09-30 | $95M |
| 2021-06-30 | $144M |
| 2021-03-31 | $222M |
| 2020-09-30 | $236M |
| 2020-06-30 | $265M |
| 2020-03-31 | $116M |
| 2019-09-30 | $204M |
| 2019-06-30 | $142M |
| 2019-03-31 | $99M |
| 2018-09-30 | $104M |
| 2018-06-30 | $135M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/EBS/gross-profit)
